Sign In
NewsRadar

Press release centre

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.
   

Past Press Releases - Life Sciences Partners (LSP)

January 20, 2016
LSP Leads Financing Round in Insulin Pump Company ViCentra
LSP (Life Sciences Partners), a leading European investor in health care, announces its investment in the Series B Round of ViCentra B.V., a private Dutch company commercializing the Kaleido insulin pump system for diabetes patients. More

November 12, 2015
LSP’s portfolio company Curetis raises EUR 40 million in successful Euronext IPO.
Our portfolio company Curetis N.V., a developer of advanced molecular diagnostic assays for severe infectious diseases in hospitalized patients, raised € 40 million in an initial public offering (IPO) through a listing in Euronext Amsterdam and Euronext Brussels. More

August 18, 2015
Kuros Announces the Successful Closing of a CHF 15m Financing Round
Kuros Biosurgery AG, a biotechnology company developing novel biomaterials and bioactive-biomaterial combination products and focused in therapeutic areas covering sealants and orthobiologics, announced today that it has closed a financing round of CHF15M. More

May 11, 2015
PMV and LSP enter into strategic partnership in life sciences
ParticipatieMaatschappij Vlaanderen (PMV) and Life Sciences Partners (LSP) today announce entering into a strategic partnership to further build and strengthen Flanders’ life sciences industry, benefitting from each other’s complementary networks, skills and expertise. More

September 30, 2014
LSP raises EUR 80 mln to invest in medical innovations
LSP (Life Sciences Partners) today announced that it has raised EUR 80 mln (USD 100 mln) for its new fund LSP 5. More

September 15, 2014
LSP’S PORTFOLIO COMPANY AFFIMED LISTED ON NASDAQ
It is with great pleasure that today, LSP – the specialist European healthcare investment firm – announces that its portfolio company Affimed was successfully listed on the NASDAQ stock exchange. More

July 10, 2014
LSP’s portfolio company arGEN-X raises targeted EUR 40 million in successful IPO on Euronext
It is with great pleasure that today, LSP – the specialist European healthcare investment firm – announces that its portfolio company arGEN-X was successfully listed on the Euronext Brussels stock exchange on Thursday July 10 under the ticker “ARGX” at a market capitalization of EUR 132 mln. More

February 10, 2012
Achmea and LSP launch the LSP-Health Economics Fund for innovation in health care
Dutch health care insurer Achmea and investment company Life Sciences Partners (LSP) have set up an investment fund for innovation in health care, the LSP-Health Economics Fund (LSP-HEF). More

January 12, 2011
LSP's portfolio company EyeSense attracts QIAGEN as strategic investor
Strategic partnership to develop and commercialize a novel ophthalmic self-diagnostic system for blood glucose monitoring by diabetes patients. More

May 27, 2010
LSP announces acquisition of portfolio company FlowCardia, Inc.
LSP is pleased to announce that its portfolio company, FlowCardia, Inc., has been acquired by C.R. Bard, Inc. Bard is a worldwide leader in products that focus on disease state management in three key areas: vascular, urology and oncology. More

September 10, 2009
LSP co-leads EUR 9.5 million Series A financing of arGEN-X
LSP (Life Sciences Partners) announced today the closure of the Series A financing round of arGEN-X, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody platform. More

December 17, 2008
LSP's portfolio company Prosensa raises EUR 18 million Series B financing
LSP's portfolio company Prosensa Holding B.V., a Netherlands based biotechnology company focused on RNA interference therapeutics using exon skipping technology, today announced that it has closed an EUR 18 million series B round. More

November 6, 2008
LSP raises € 75 mln for new life sciences venture fund
GSK and Pfizer among the investor group. More

May 21, 2008
LSP announces acquisition of portfolio company U3 Pharma AG
LSP announced today that it has entered into an agreement with Daiichi Sankyo Co. Ltd. for Daiichi Sankyo to acquire LSP portfolio company, U3 Pharma AG. More

April 28, 2008
APG and LSP announce strategic investment relationship
The LSP (Life Sciences Partners) Group, the European life sciences investment group, today announces the establishment of a strategic investment relationship with APG Investments. More

January 15, 2008
LSP co-leads CHF 17.0 million Series A financing of Vivendy Therapeutics AG
LSP today announced the closing of a CHF 17.0 million Series A round of Vivendy Therapeutics Ltd., a bio-pharmaceutical company located in Basel, Switzerland. More

December 19, 2007
BMEYE announces FDA 510(K) clearance for Nexfin
LSP’s portfolio company BMEYE announced that it has received 510(K) clearance from the U.S. Food and Drug Administration (FDA) to market Nexfin, their newly developed line of safe, precise and easy to use hemodynamic monitors. More

October 5, 2007
LSP co-leads Series A financing round of Skyline Diagnostics
LSP (Life Sciences Partners) announced today the closure of the Series A financing round of Skyline Diagnostics B.V. More

September 10, 2007
LSP's portfolio company IDEA AG agrees on $ 202 million licensing deal with Alpharma
LSP announces today that the German drug delivery company IDEA AG has agreed with an affiliate of Alpharma Inc., Bridgewater/NJ to license the exclusive United States rights to Diractin (ketoprofen in Transfersome, formerly known as IDEA-033) as a prescription topical NSAID (non-steroidal anti-inflammatory drug) in the US. More

August 8, 2007
LSP BioVentures leads $10 million Series C investment in BioProcessors
LSP BioVentues announces today that it has lead the closing of a $10 million Series C equity investment round in BioProcessors Corporation, the leading provider of micro-engineered solutions for biopharmaceutical process development applications for the biotechnology and pharmaceutical industries. More

Data


23,644
Tech investments
From our Online Data Service
15,269
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Dec 10€2.3MSoftware development
Dec 6€5.0MIT services
Dec 5€26.0MEnergy related
Dec 5€5.5MSecurity
Dec 5€16.0MKnowledge management
Dec 4€25.0MBiopharmaceuticals
Dec 4€8.0MInternet services

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


Aug 17
Komed Health
komed health closes seed financing round

Jul 10
Komed Health
komed health to be supported by nokia and deutsche telekom

May 4
Vivet Therapeutics
vivet therapeutics raises €37.5 million in series a

Apr 5
Fliit
logistik-start-up fliit sammelt 1.5 millionen bei seed-finanzierung...

Jan 24
Spendesk
in addition to online payments, spendesk is now tackling travel exp...





About usContact usLegal Information
Copyright © 1999-2017
Emerging Technology Research Europe Inc. All rights reserved.